Manulife (Manufacturers Life Insurance)
ORGO icon

Manulife (Manufacturers Life Insurance)’s Organogenesis Holdings ORGO Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.8K Sell
18,018
-2,655
-13% -$6.49K ﹤0.01% 2860
2026
Q1 		$49K Sell
20,673
-1,150
-5% -$3.98K ﹤0.01% 2742
2025
Q4 		$113K Sell
21,823
-2,909
-12% -$14.1K ﹤0.01% 2681
2025
Q3 		$104K Sell
24,732
-2,294
-8% -$10.7K ﹤0.01% 2771
2025
Q2 		$98.9K Sell
27,026
-133
-0.5% -$496 ﹤0.01% 2760
2025
Q1 		$117K Sell
27,159
-1,542
-5% -$6.23K ﹤0.01% 2659
2024
Q4 		$91.8K Sell
28,701
-949
-3% -$3.18K ﹤0.01% 2838
2024
Q3 		$84.8K Sell
29,650
-1,334
-4% -$3.74K ﹤0.01% 2903
2024
Q2 		$86.8K Buy
30,984
+4,130
+15% +$11.1K ﹤0.01% 2858
2024
Q1 		$76.3K Sell
26,854
-2,911
-10% -$9.89K ﹤0.01% 2838
2023
Q4 		$122K Sell
29,765
-1,903
-6% -$5.33K ﹤0.01% 2766
2023
Q3 		$101K Hold
31,668
– – ﹤0.01% 2807
2023
Q2 		$105K Buy
31,668
+1,808
+6% +$5.34K ﹤0.01% 2831
2023
Q1 		$63.6K Hold
29,860
– – ﹤0.01% 2827
2022
Q4 		$80.3K Buy
29,860
+146
+0.5% +$426 ﹤0.01% 2848
2022
Q3 		$96.3K Sell
29,714
-947
-3% -$4.28K ﹤0.01% 2818
2022
Q2 		$150K Buy
30,661
+1,873
+7% +$11.5K ﹤0.01% 2794
2022
Q1 		$219K Buy
28,788
+6,807
+31% +$52.7K ﹤0.01% 2716
2021
Q4 		$203 Buy
21,981
+322
+1% +$3.42K ﹤0.01% 2881
2021
Q3 		$308K Sell
21,659
-1,576
-7% -$24.5K ﹤0.01% 2654
2021
Q2 		$386K Buy
23,235
+7,845
+51% +$146K ﹤0.01% 2612
2021
Q1 		$280K Buy
+15,390
New +$209K ﹤0.01% 2663

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s ORGO Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Organogenesis Holdings (ORGO) stake by 13% in Q2 2026, selling an estimated $6.49K and leaving 18,018 shares worth $43.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2860.

Manulife (Manufacturers Life Insurance) first reported a position in ORGO in Q1 2021 and has held it in 22 quarters since. The position peaked at $386K in Q2 2021. 134 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) held 18,018 shares of Organogenesis Holdings worth $43.8K as of Q2 2026.
  • Manulife (Manufacturers Life Insurance) sold 2,655 Organogenesis Holdings shares in Q2 2026, an estimated $6.49K.
  • Organogenesis Holdings made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #2860 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Organogenesis Holdings in Q1 2021 and has held it in 22 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Organogenesis Holdings position peaked at $386K in Q2 2021.
  • 134 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.